Stay updated on BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.

Latest updates to the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedA new revision note (v3.3.3) was added and an older revision note (v3.3.2) plus the HHS Vulnerability Disclosure link were removed. These changes reflect administrative footer updates.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedSite version updated from v3.2.0 to v3.3.2; no visible changes to trial data or the Record History page.SummaryDifference0.0%

- Check39 days agoChange DetectedNotice about a government funding lapse was removed from the page. This is an operational update and does not affect the trial data or history content.SummaryDifference0.3%

- Check60 days agoChange DetectedThe new screenshot primarily updates styling and layout, while the underlying version history entries and statuses remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check82 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference9%

- Check89 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%

Stay in the know with updates to BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.